Agoracom Blog Home

Author Archive

VIDEO: Affinity Metals $AFF.ca Discusses Significant Silver Discovery at their Regal Project in B.C $SII.ca $TUD.ca $GTT.ca $AMK.ca $OSK.ca $RKR.ca

Posted by AGORACOM-JC at 9:37 AM on Wednesday, April 22nd, 2020
Affinity Metals Corp. Enters into Agreement to Acquire the Regal ...

Rob Edwards discusses the extraordinary exploration results at the ALLCO Project and the implications of discovering such a significant discovery hole at their Regal Pollymettalic Property in the Kootenay Arc, B.C.

The numbers show there is a considerable source of mineralization on the property to create 11.10 meters of 143.29 g/t silver including 0.55 meters of 2612.0 g/t,   only further exploration will continue to define the limits of the Allco area and other the Major targets Affinity has plans for developing during the 2020 exploration season.

Take a seat and grab your favorite beverage and have a listen to the remarkable story that is Affinity Metals.

Datametrex $DM.ca Awarded $217,000 by Department of National Defence for Completion of Phase 2 of Innovation Program

Posted by AGORACOM-JC at 8:50 AM on Wednesday, April 22nd, 2020
  • Department of National Defence approved the Company’s completion of the second phase of a multi-phase R&D program through the Department of National Defence’s Innovation for Defence Excellence and Security (IDEaS) program
  • Datametrex will be receiving approximately $217,000 CAD as payment for completion of phase 2
  • Company will continue to work on phase 3 of the program to further develop Nexalogy SMART, Social Media Automated Reporting Technologies

TORONTO, April 22, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the Department of National Defence approved the Company’s completion of the second phase of a multi-phase R&D program through the Department of National Defence’s Innovation for Defence Excellence and Security (IDEaS) program. Datametrex will be receiving approximately $217,000 CAD as payment for completion of phase 2.  The Company will continue to work on phase 3 of the program to further develop Nexalogy SMART, Social Media Automated Reporting Technologies. Due to confidentiality requirements, the Company is not permitted to provide additional details about the nature of the work being performed for the Department of National Defence.

IDEaS supports the development of solutions from their conceptual stage, through prototype testing and capability development. The program includes several elements that promote collaboration between innovators, provides developmental resources and provides opportunities to interact with DND’s science and military members. Through which all innovators are on an even playing field to solve specific defence and security challenges. For more info about the program, see here: https://www.canada.ca/en/department-national-defence/programs/defence-ideas.html

“The completion of phase 2, marks the halfway point of this project and reflects the important work we are doing to help the Government of Canada maintain a technological advantage in the realm of cyber social media security. We are happy to have the go ahead to continue the contract.” says Marshall Gunter, CEO of the Company.

For more information on this project or to learn how Datametrex can assist your organization in social media discovery or cyber security please go to: www.nexalogy.com

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

For more information about the IDEaS program please visit: Canada.ca/defence-ideas

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Empower Clinics $CBDT.ca Continues to Advance Development of #Psilocybin and Psychedelics Division to Address Significant Mental Health Issues $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:20 AM on Wednesday, April 22nd, 2020

Empower is utilizing clinics, physicians, technology and direct access to 165,000 patients to launch dedicated division and resources for psilocybin research.

  • Created a subsidiary company dedicated to the advancement of psilocybin research and patient care, addressing the significant mental health issues of anxiety, depression, post-traumatic stress disorder and addiction
  • “Mental health conditions such as anxiety, depression, addiction and PTSD appear to be on the rise with the onset of the Coronavirus pandemic.” said Steven McAuley, Chairman & CEO of Empower

VANCOUVER, BC / April 22, 2020 / EMPOWER CLINICS INC. (CSE: CBDT)(OTC: EPWCF)(Frankfurt 8EC) (“Empower” or the “Company”), a vertically integrated and growth-oriented life sciences company is pleased to announce, it is has created a subsidiary company dedicated to the advancement of psilocybin research and patient care, addressing the significant mental health issues of anxiety, depression, post-traumatic stress disorder (PTSD) and addiction.

The Company is leveraging its assets that include the existing clinic network, the developing franchise brand, tele-medicine, access to its 165,000 patients and large physician team, to make advancements in psilocybin research and psychedelics therapy in general.

“Mental health conditions such as anxiety, depression, addiction and PTSD appear to be on the rise with the onset of the Coronavirus pandemic.” said Steven McAuley, Chairman & CEO of Empower. “Clinical trials continue to show that psilocybin therapies may provide tremendous help with these conditions, that we see every day in our clinics. As a Company, we must endeavour to utilize our assets and capabilities to positively impact patients’ lives.”

The mental health crisis could cost the world $16 trillion by 2030 according to Future Market Insights and further, the global behavioral health (non-pharmacological) market is expected to be valued at US$156 billion by 2028.

According to the World Health Organization (WHO), depression is the leading cause of disability worldwide, and it is a major contributor to the overall global burden of disease.

The United States Food and Drug Administration has determined that preliminary clinical evidence indicates psilocybin may demonstrate substantial improvement over other available therapies for treatment-resistant depression; and granted a Breakthrough Therapy designation for a treatment that uses psilocybin as a therapy for such depression.

ABOUT EMPOWER

Empower is a vertically integrated health & wellness brand with a network of corporate and franchised health & wellness clinics in the U.S. The Company is building its first hemp-derived CBD extraction facility and produces its proprietary line of cannabidiol (CBD) based products. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley

CEO

[email protected]

604-789-2146

Investors: Dustin Klein

SVP, Business Development

[email protected]

720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to create psilocybin and psychedelics divisions, that market research on advancements in psilocybin and psychedelics in North America and globally will create greater shareholder value, the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Psychedelic substances remain illegal in most countries, so please reference your local laws in relation to medical or recreational use. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

VIDEO: Datametrex $DM.ca Discusses Obtaining Rights to Import and Sell #COVID19 Test Kits From South Korea

Posted by AGORACOM-JC at 4:29 PM on Tuesday, April 21st, 2020

When US Government Agencies call you in the middle of the greatest health and economic crisis in 100 years to help them detect social media disinformation about COVID-19, it is safe to assume your Artificial Intelligence capabilities to detect fake news, disinformation campaigns and their impact is amongst the most respected in the world.  

But when the Canadian government calls on you to help with the import and sale of COVID-19 test kits from South Korea, it is also safe to assume your trust and security clearances are at the highest levels possible.    

You would probably also assume such a company to be a tech giant or a Silicon Valley funded startup.  But Datametrex AI (DM: TSXV) is neither.  Rather, it is a great Canadian small cap technology company who happens to have:  

“developed strong relationships with many large multi-national companies in South Korea.  As a result of these relationships, the Canadian Embassy in Seoul contacted Datametrex to ask for help in procuring rapid test kits.”

  If that wasn’t enough, Datametrex has also achieved the following as of late:

  • Q3 Revenues Of $1.6 million,  an increase of 186%
  • 9 Month Revenues Of $2.56M an increase of 37%
  • Repeat Contracts Of $1M and $600,000 With Korean Giant LOTTE   
  • $954,000 Contract With Canadian Department of Defence To Fight Social Media Election Meddling
  • Participation In NATO Research Task Group On Social Media Threat Detection 
  • Becoming an affiliate member of the Carnegie Mellon University Center for IDeaS

When a small cap Artificial Intelligence company is successfully deploying its technology with military and conglomerates, as well as, being called upon by the Canadian federal government to ask for help with the greatest pandemic in 100 years, smart small cap investors are compelled to take a closer look.  

That look can begin with our latest interview of Datametrex CEO, Marshall Gunter, who discusses obtaining the rights to import and sell COVID-19 test kits from South Korea and the impact it will have on the Company.  

Watch this interview on one of your favourite screens or hit play and listen to the audio as you drive. 

CLIENT FEATURE: Tartisan Nickel $TN.ca Kenbridge Property Hosts M&I Resource of 7.14 Million Tonnes of 0.62% Nickel + 0.33% Copper – $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 2:05 PM on Tuesday, April 21st, 2020
Tc logo in black

Investment Highlights

  • Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
  • 17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property

Kenbridge Ni Project (ON, Canada)

  • Advanced  stage  deposit  remains open  in  three  directions,  is  equipped with a 623m  deep  shaft  and  has  never  been  mined
  • Preliminary  Economic Assessment completed and updated returned robust project 
    economics and operating costs including  a  NPV  of  C$253M  and  cash costs of US$3.47/lb of nickel net of  copper credits
  • Plans for Kenbridge include updating PEA, advancing the project through to feasibility and exploring the open mineralization at depth

Recent News

  • Company has completed a Spectral Analysis Survey
  • Survey covered the patented and single-cell mining claims that make up the historic land position which contains the Kenbridge Deposit and the surrounding area, identifying several new exploration targets not only for nickel, copper, cobalt, but also for potential gold occurrences
  • Analysis Survey shows the distribution and intensity of up to 304 minerals, with the first pass showing up to 16 minerals
  • Each mineral can be classified into an exploration relevance for base metals, precious metals and industrial metals

Tartisan CEO Mark Appleby said, “the survey picked out the Kenbridge Deposit, and has shown the possible extension to the Kenbridge Deposit and three additional trends that relate directly to underlying geology and structure implicit in the Kenbridge Deposit. Of significant interest, the survey found two gold trends as well, which include the Violet and Nina historic gold occurrences. One of the occurrences is almost 54 hectares in size and covers almost all of three of our staked claims on the border of the Kenbridge property.”

Industry News

INDUSTRY BULLETIN: Nickel prices jump after Vale trims output target

INDUSTRY BULLETIN: Nickel prices get a boost from pandemic-driven ore supply tightness

INDUSTRY BULLETIN: Have the next crop of battery metals producers been oversold?

INDUSTRY BULLETIN: The thematic case for nickel

Click Here to View Kenbridge 43-101 Technical Report

FULL DISCLOSURE: Tartisan Nickel Corp. is an advertising client of AGORA Internet Relations Corp.

MUST WATCH: KABN Systems North America Online “Ask Me Anything” Event

Posted by AGORACOM-JC at 12:28 PM on Tuesday, April 21st, 2020

KABN Systems North America is in the business of verifying, managing and monetizing online Digital Identity.

Digital Data is the new “Gold”!

KABN North America empowers users to verify, protect, manage and profit from their Digital Identity.  With the recent changes to working, shopping, educating and playing from home, online usage and engagement is growing.

KABN’s business is:

  • About providing consumers with no-cost tools to manage their Digital Identity and profit from the public data.
  • Focused online making us Covid-19 resistant.
  • Relevant to 100% of the online, digital market.
  • Optimized for commercial partnerships in Financial Services, eCommerce, Education, Government, Healthcare, Technology, Gaming & more.
  • Built, scalable, proven and in market today.
  • Aligned with online revenue trends.
  • Run by a veteran team of successful industry leaders.
  • In process of a proposed RTO transaction for public listing.

PyroGenesis $PYR.ca Receives Additional $457K Under Exclusive Agreement with US Tunneling Company $RTN $NOC $UTX $HPQ.ca $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 11:09 AM on Tuesday, April 21st, 2020
  • Announced today that, further to its press release dated April 1st, 2020, it has received an additional US$325K (approx. CA $457K) under the exclusive agreement with a US based tunneling company
  • To date, the Company has received US $725K (over CA $1M) in total

MONTREAL, April 21, 2020  — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to announce today that, further to its press release dated April 1st, 2020, it has received an additional US$325K (approx. CA $457K) under the exclusive agreement (the “Agreement”) with a US based tunneling company (the “Client”). To date, the Company has received US $725K (over CA $1M) in total. The Client’s name will remain anonymous for confidentiality and competitive reasons.

“This is an ideal contract, given the current situation, where all the engineering work can be done remotely,” said Mr. Peter Pascali, CEO of PyroGenesis Canada Inc. “This relationship is timely, given the current environment where investors are more focused on multiple secure revenue streams.  It is important to note that this relationship was not born out of the current crisis and, as such, is expected to continue well after the pandemic is behind us.”

Under this Agreement, PyroGenesis will not only develop and supply high-powered plasma torches, specifically designed for tunneling applications, but will also be intimately involved in all aspects of design and development for the entire project. Upon success, the Client is committed to purchase exclusively, and PyroGenesis is committed to exclusively supplying, plasma torches and auxiliary equipment for these applications. The scope of work is now comprised of several phases, each being defined by the results from the former.

PyroGenesis’ high-powered plasma torch will be used to replace traditional tunneling methods. An important benefit in using plasma-based tools versus traditional methods, is its potential to drill through all geologies with greater flexibility in size diameter, while at the same time being more economical, efficient and environmentally friendly.

“Once again, this Agreement underscores our plasma torch expertise, and we are pleased to be applying it to a very unique and significant opportunity,” said Mr. Alex Pascali, Business Development Manager of PyroGenesis. “This highlights the fact that we not only sell plasma torches, but also provide the expertise required to develop cutting edge plasma-based applications. The Company continues to increase revenues and reduce risk by diversifying its customer base with a standard product offering.  This is just one of many exciting developments at PyroGenesis these days.”

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected]
RELATED LINK: http://www.pyrogenesis.com/

Datametrex $DM.ca Provides Update On Health Canada Submission & Welcomes Advisors

Posted by AGORACOM-JC at 7:12 AM on Tuesday, April 21st, 2020
  • Provides additional specifics on the previously announced news release regarding acquiring the rights to import COVID-19 test kits from South Korea
  • An application for approval was made to Health Canada under the Fast-Track program on April 9th, 2020
  • As part of the submission, the Company has submitted a Medical Devices Interim Order Request Form under Interim Order
  • Interim Order (IO) will allow Health Canada to issue expedited review and approval for the sale of these test kits in Canada

TORONTO, April 21, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF ) wishes to provide additional specifics on the previously announced news release regarding acquiring the rights to import COVID-19 test kits from South Korea. An application for approval was made to Health Canada under the Fast-Track program on April 9th, 2020.

As part of the submission, the Company has submitted a Medical Devices Interim Order Request Form under Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act signed by the Minister of Health on March 18, 2020. This Interim Order (IO) will allow Health Canada to issue expedited review and approval for the sale of these test kits in Canada.

The Company has represented to Health Canada that it will be able to provide a minimum first order of 200,000 units, followed by an additional 100,000 units on a weekly basis. Any purchase of the test kits by the Canadian government is conditional on prior receipt of Health Canada approval. Datametrex is currently working with Dr. Lisa Palleson-Stallan and Dr. Joseph Curtis to assist with obtaining Health Canada approval, and each has agreed to join the Company’s advisory board.

Dr. Joseph Curtis is the Chief Scientific Officer and founder of BioQuant Laboratories (BQL) an independent testing laboratory providing analytical testing services to firms across the U.S. and Canada developing natural product medicines for human and animal health. Dr. Curtis has twenty-five years of experience across and has held various executive positions within public and private sector firms. Working across the public health emergency medical countermeasures continuum, he supported the USA’s blood and tissue preparedness and response programs managed by the American Red Cross. In this capacity, he served as the Director, Biomedical Headquarters Facility Quality Assurance coordinating performance excellence programs across a nation-wide network of manufacturing and testing facilities delivering $2 billion of cellular therapies and transfusion medicine products to over 3,000 hospitals across the US.

Dr. Lisa Palleson-Stallan obtained her Ph.D in International Business with Honours in the U.K. She ran a European Union funded project on technology and Innovation and completed post doctoral work at the World Health Organization (WHO) publishing on Tobacco Cessation. She created her first retail company, Lotuswear, which grew into a 100 employee + company and had the role as presidentand CEO. She became an early adopter in several industries and has continued building value from the ground up. She has built a successful consultancy company that targets the Asian marketplace within the Health space. Dr Palleson-Stallan has been given role and title of Global Health Advisor to assist the Chinese Government with unconditional support and authority to conduct negotiations regarding how to best to combat the spread of Covid-19.

“We are thrilled to be in a position to bring high quality test kits to Canada to help flatten the curve and save lives. We are doing everything we can to provide Health Canada with the required information to move forward. We are looking forward to solving these problems alongside Dr. Palleson-Stallan and Dr. Curtis.”, says Marshall Gunter, CEO of the Company.

Datametrex anticipates that it will have little or no upfront costs associated with importing these test kits. Assuming Health Canada approves the test kits and they are subsequently purchased by the Canadian government, manufacturer will ship the test kits directly to the Canadian government or hospitals, and Datametrex will not be involved in the shipping, warehousing or distribution process.

About Datametrex AI Limited

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com).
Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Jeff Stevens – Co-Founder
Phone: (647) 400-8494
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

NORTHBUD $NBUD.ca – Virtual 4/20: How the #Cannabis Industry Is Adapting Its Signature Holiday for Quarantine $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 9:30 PM on Monday, April 20th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. The company recently received Canadian Cultivation Licence for its Quebec Facility. Learn More.

Virtual 4/20: How the Cannabis Industry Is Adapting Its Signature Holiday for Quarantine

Dispensaries get creative, and celebrities join in, as gatherings give way to livestreams

  • Despite all the gloom facing society as 4/20 approaches, it’s predicted to be a massive sales day, contributing to what BDS Analytics thinks will be a 30% jump in retail cannabis sales this year to $17 billion.

  By T.L. Stanley Harvest House of Cannabis  

Many cannabis fans are as devoted to their unofficial holiday, April 20, as some people are to Christmas, Halloween or the Fourth of July. In recent years, as cannabis has grown in mainstream acceptance and legality, 4/20 has been marked with parties and concerts, stadium-sized festivals and pot versions of pub crawls.

But not this year, as the coronavirus response has blocked public gatherings, gutted the experiential industry, canceled nearly every major 4/20 event and substantially altered marketers’ approaches  to the day.

The celebrations will go on, though, as organizers pivot from real-world to virtual gatherings, lining up talent like Wiz Khalifa, Billy Ray Cyrus, Berner and Kid Astronaut for marathon live streams that revelers can watch from the safety of their couches.

Delivery services are prepped for heavy volume in the wake of a record-setting mid-March sales surge, and brands in the space are giving consumers quarantine-friendly ideas to replace their usual in-person meetups and smokeouts. “This is a chance for the cannabis community to model to the rest of the world how holidays should be handled during periods of social crisis.” —Steve DeAngelo, co-founder, Harborside dispensary

Dispensaries in states where they’re considered “essential businesses”—and therefore allowed to stay open, while following strict safety protocols and social distancing rules—are leaning into their curbside pickup and contactless delivery options. They’ll be trying to discourage exactly the kinds of crowds at their venues that they’ve actively fostered in the past.

Mainstream, non-cannabis brands that have latched onto the holiday with psychedelic stoner-cliched ads and memes may sit it out all together, similar to this year’s approach to April Fools’ Day, so as not to appear flip or insensitive (or simply wasteful with their resources) during the current pandemic and economic downturn.

All things considered, 4/20 is expected to shed some of the raucous overkill and “amateur night” feel of the recent past in favor of a more thoughtful, subdued vibe.  

“You don’t generally associate 4/20 with restraint,” says Steve DeAngelo, a longtime cannabis activist and co-founder of the Harborside dispensary chain in the Bay Area. “But this is a chance for the cannabis community to model to the rest of the world how holidays should be handled during periods of social crisis.”

Taking no chances, the mayor of San Francisco has publicly warned cannabis devotees not to travel to or gather in the famously open-minded destination, known for its 4/20 meet-ups in places like Golden Gate Park. “We will cite people. We will arrest people if necessary,” London Breed says in an Instagram video. And the Washington State Liquor and Cannabis Board sent out a list of do’s and don’ts to licensed businesses, telling them not to schedule events, hire food trucks or live bands or try in any way to attract large crowds.

Another green rush

Despite all the gloom facing society as 4/20 approaches, it’s predicted to be a massive sales day, contributing to what BDS Analytics thinks will be a 30% jump in retail cannabis sales this year to $17 billion. 

One of the previous high water marks for the industry was April 20, 2019, when recreational cannabis sales increased more than 100%, versus the prior week, in states like California, Colorado, Nevada and Washington, according to cannabis data firm Headset.

“Since 4/20 is on a Monday this year, the sales uptick could start over the weekend or maybe even mid-week,” says Liz Connors, Headset’s director of analytics.

Weedmaps, a national cannabis delivery platform, is girding for a second green rush, following the March spike in sales as stay-at-home mandates were announced. “Conservative estimates could very well put us around eight times the order volume over our baseline, and four to five times what we typically see on this holiday annually,” according to CMO Juanjo Feijoo.

Source: https://www.adweek.com/creativity/virtual-4-20-how-the-cannabis-industry-is-adapting-its-signature-holiday-for-quarantine/

Nickel prices jump after Vale trims output target – SPONSOR Tartisan #Nickel $TN.ca – $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 9:15 PM on Monday, April 20th, 2020

SPONSOR: Tartisan Nickel (TN:CSE)  Kenbridge Property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper. Tartisan also has interests in Peru, including a 20 percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property. Click her for more information

Tc logo in black

Nickel prices jump after Vale trims output target

  • Vale cuts 2020 output for nickel, copper
  • “Vale’s cut to production has supported the market but mines closing production is not too new as we knew some mines would shut,” said Commerzbank analyst Daniel Briesemann.

By Zandi Shabalala

LONDON, April 20 (Reuters) – Nickel prices jumped to their highest in more than a month on Monday after mining company Vale slashed its annual output target for the stainless steel ingredient due to the impact of the coronavirus pandemic.

Benchmark nickel on the London Metal Exchange (LME) was 4% higher at $12,520 per tonne at 1600 GMT, after earlier jumping to its highest since March 13 at $12,535.

“Vale’s cut to production has supported the market but mines closing production is not too new as we knew some mines would shut,” said Commerzbank analyst Daniel Briesemann.

“The negative impact of the virus is more severe for the demand side and the market could be well oversupplied this year.”

Vale, one of the world’s top producers of nickel, cut its 2020 production forecast for the metal to 180,000-195,000 tonnes from 200,000-210,000, excluding its unit in New Caledonia, because of the impact of the novel coronavirus outbreak.

Japan’s Sumitomo Corporation has also shut down output at a nickel mine in Madagascar while major nickel producer the Philippines closed some of its mines to curb transmission of the virus.

CHINESE DEMAND: Demand for nickel picked up slightly in March as China reopened its economy. Stainless steel futures surged as much as 4.4% on Monday.

2020 BALANCE: Despite the mounting supply cuts, a Reuters poll showed that the nickel market is expected to be in surplus of 89,000 tonnes this year.

CHINA ECONOMY: China, the world’s top metals consumer, cut its interest rate for a second time after its economy contracted for the first time in decades. The move – which was widely expected – is aimed at cushioning the world’s second largest economy against the impact of the coronavirus.

COPPER SMELTING: Global copper smelting slid in March, driven by shutdowns in China but started to recover at the end of the month, according to an index based on satellite surveillance of copper plants.

ALUMINIUM INVENTORIES: Aluminium stocks in LME-registered warehouses soared 46,275 tonnes, helping to lift inventories available to the market to 1.18 million tonnes which is the highest since Dec. 20. MALSTX-TOTAL

SPREAD: The discount of LME cash aluminium to the three-month contract CMCU0-3 was at $37.75 a tonne, reflecting expectations for oversupply.

Read More: https://www.reuters.com/article/global-metals/metals-nickel-prices-jump-after-vale-trims-output-target-idUSL4N2C82C3